In a significant judicial decision reinforcing India’s strict statutory framework against drug trafficking, the Special NDPS Court in Bengaluru has rejected the bail application of a foreign national, Baraka Salemani Chau, who was arrested in possession of 150 grams of MDMA Crystal. Smt. B.S. Jayashree, the XXXIII Additional City Civil and Sessions Judge and Special Judge for NDPS cases, delivered the order in Criminal Miscellaneous Petition No. 6408/2022, holding that the massive recovery of commercial-quantity psychotropic substances invokes the stringent mandate of Section 37 of the NDPS Act.
The legal proceedings stemmed from an operation led by the Central Crime Branch (CCB) attached to the Banaswadi Police Station. On May 19, 2022, at approximately 11:30 AM, law enforcement officers received specific intelligence that a foreign national was actively distributing narcotic drugs to local buyers and college students in front of the Hab Hotel, located at 3rd Cross, HRBR Layout, Kalyanagar, Banaswadi. Following statutory protocols, the police team obtained necessary authorization from superior officers and rushed to the location alongside independent panchas.
Upon arriving at the scene, law enforcement officers surrounded and detained the suspect. During initial questioning, he identified himself as Baraka Salemani Chau, aged 28, residing at Srinivasa Apartment, Byrathi Cross, Kanakanagar, Bengaluru. A subsequent search of the accused led to the recovery and seizure of 150 grams of MDMA Crystal. Police executed a comprehensive spot mahazar, formally arrested the accused, and filed a detailed investigation report. The Banaswadi Police subsequently registered Crime No. 233/2022 under Sections 8(c) and 21(c) of the Narcotic Drugs and Psychotropic Substances Act, 1985, along with Section 14 of the Foreigners Act, following which the jurisdictional magistrate remanded the accused to judicial custody.
Representing the accused, advocate D.P. filed a petition under Section 439 of the Code of Criminal Procedure seeking release on bail. The defense asserted that the petitioner was innocent, law-abiding, and completely unconnected to the seized illicit drugs, alleging that he was falsely implicated by the investigating authorities. Counsel further argued that mandatory search and seizure procedures under the NDPS Act were breached, that the major portion of the investigation was already concluded, and that continued custodial interrogation was unnecessary.
The prosecution, represented by the Public Prosecutor, vigorously opposed the petition, highlighting the gravity of the charges. The State pointed out that under Ministry of Finance Notification S.O.1055(E) dated October 19, 2001 (Entry No. 134), any quantity of MDMA exceeding 10 grams is categorized as a commercial quantity. Because the seized quantity of 150 grams exceeds the threshold by fifteen times, the alleged offenses attract rigorous imprisonment ranging from 10 to 20 years along with hefty monetary fines. The prosecution emphasized that as a foreign national involved in catering illegal drugs to youth, releasing the petitioner would pose a severe risk of absconding, witness tampering, and re-engaging in drug syndicates.
Delivering the order, Judge B.S. Jayashree conducted an extensive analysis of Section 37(1)(b) of the NDPS Act, emphasizing that the law mandates a twin condition test before bail can be considered in commercial quantity cases. The court referred to authoritative judgments of the Supreme Court of India, including State of Kerala v. Rajesh (2020), State of MP v. Kajad (2001), Union of India v. Mohammed Nawaz Khan (2021), and Babua v. State of Orissa (2001).
The court reiterated that under Section 37, the negation of bail is the rule and its grant is a rare exception. Judicial release requires the court to be satisfied on “reasonable grounds”—meaning substantial probable cause rather than mere prima facie arguments—that the accused is not guilty of the alleged offense and is unlikely to commit any crime while on bail. The court observed that liberal approaches toward bail in commercial drug cases run contrary to legislative intent and societal protection.
Addressing the defense’s claims regarding procedural defects under Section 42 of the NDPS Act, the court noted that such procedural nuances constitute matters of trial fact rather than grounds for summary release at the bail stage. Finding clear prima facie evidence of conscious possession of a large commercial quantity of MDMA, and noting that the defense failed to present any material to demonstrate non-involvement, the Special Court held that the petitioner failed to satisfy the legal criteria for bail. Consequently, on July 21, 2022, the court formally dismissed the bail petition.